Emphymab Biotech

Emphymab Biotech is developing a first disease-modifying drug for emphysema and other chronic diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Indianapolis, IN, USA
  • Currency USD
  • Founded May 2011
  • Employees 4

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free